Spontaneous Spinal Epidural Hematoma After Combined Urokinase and Heparin Thrombolytic Therapy for Deep Venous Thrombosis

Abstract

The literature clearly supports the view that all anticoagulation therapy is associated with a significant risk of hemorrhagic complications. Combining anticoagulation and fibrinolytic therapy further adds to this risk. Moreover, in the treatment of deep venous thrombosis the combined use of heparin and fibrinolytic therapy is not necessarily associated with a better outcome. Close monitoring of the clotting profile has not eliminated the risks since a correlation between laboratory parameters and bleeding complications has not been demonstrated. Furthermore, the appropriate total dose and duration of therapy remain unclear.

The authors report an especially devastating complication of spinal epidural hematoma with resultant paraplegia after combined use of heparin and urokinase for iliofemoral venous thrombosis in an otherwise healthy young woman. The dramatic nature of the complications illustrates the need for continued analysis of this therapeutic strategy.

Get full access to this article

View all access options for this article.

References

1. Harik SL , Raichle ME , Reis DJ : Spontaneously remitting spinal epidural hematoma in a patient on anticoagulants. N Engl J Med 284:1355-1357, 1971.

2. Mustafa MH , Gallino R : Spontaneous spinal epidural hematoma causing cord compression after streptokinase and heparin therapy for acute coronary artery occlusion. South Med J 81:1202-1203, 1988.

3. Krolick MA , Cintron GB : Spinal epidural hematoma causing cord compression after tissue plasminogen activator and heparin therapy. South Med J 84:670-671, 1991.

4. Goldhaber SZ , Burning JE , Lipnick RJ , et al: Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep vein thrombosis. Am J Med 76:393-397, 1984.

5. Mand MJ , O'Brien BD , Thong KL , et al: Hemorrhagic complications of heparin therapy. Lancet 1:1133-1135, 1977.

6. Stewart JH , Olin JW , Graor RA : Thrombolytic therapy, part 1. Cleveland Clinic J Med 56:189-196, 1989.

7. National Institutes of Health Consensus Panel . Thrombolytic therapy in thrombosis, a National Institutes of Health consensus development conference. Ann Intern Med 93:141-144, 1980.

8. Urokinase-Streptokinase Pulmonary Embolism Trial . Phase 2 results. JAMA 229:1606-1613, 1974.

9. Trubestein G , Brecht T , Ludwig M , et al: Fibrinolytische therapie mit streptokinase und urokinase bei tiefer venenthrombose. In: International Symposium on Fibrinolytic Therapy, ed. by Trubestein G , Etzel F . Stuttgart, Germany: Shattauer Verlag, 1983, pp 193-201.

10.

10. Graor RA , Risius B , Young JR , et al: Low dose streptokinase for selective thrombolysis: Systemic effects and complications. Radiology 152:35-39, 1984.

11.

11. Semba CP , Dake MD : Aggressive therapy of iliofemoral deep venous thrombosis using catheter-directed thrombolysis. Radiology (in press).

12.

12. Marder VJ , Soulen RL , Atichartakarn V , et al: Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med 89:1018-1029, 1977.

13.

13. Mori KW , Bookstein JJ , Heeney DJ , et al: Selective streptokinase infusion: Clinical and laboratory correlates. Radiology 148:677-682, 1983.

14.

14. Marder VJ , Sherry S : Thrombolytic therapy: Current status. N Engl J Med 318:1512-1520 and 318:1585-1595, 1988.